Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 114, 105132
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatmentEuropean Journal of Medicinal Chemistry, 2020
- Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screeningEuropean Journal of Medicinal Chemistry, 2020
- HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitorsEuropean Journal of Medicinal Chemistry, 2018
- Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinomaApoptosis, 2016
- Discovery of the First Histone Deacetylase 6/8 Dual InhibitorsJournal of Medicinal Chemistry, 2013
- Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitorsBioorganic & Medicinal Chemistry, 2012
- Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agentsBioorganic & Medicinal Chemistry Letters, 2011
- Modified Cap Group Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitor Derivatives Reveal Improved Selective Antileukemic ActivityJournal of Medicinal Chemistry, 2010
- FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell LymphomaThe Oncologist, 2007
- Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitorsNature, 1999